Brian Vandahl
Brian Stidsen Vandahl, Ph.D. is Senior Vice President of Global Research Technologies at Novo Nordisk and heads the Greater Copenhagen Hub for Novo Nordisk Research & Early Development. He leads an organization innovating in the protein, peptide, and chemistry field by enabling drugability, fueling early pipeline development, and driving patient-centered drug innovation for optimal target product profiles and large-scale manufacturing feasibility.
Brian joined Novo Nordisk in 2006 as a research scientist and has previously held various roles of increasing responsibility at the company, including Director of Protein Structure and Interaction, Director of Injectable Formulation Research, and Corporate Vice President of Recombinant Technologies.
Before joining Novo Nordisk, Brian worked in malaria vaccine research at the National Serum Institute in Denmark (Statens Serum Institut). Prior to this, Brian was Assistant Professor at Aarhus University, Denmark, in the Department of Medical Microbiology and Immunology. He holds an M.Sc. in Molecular Biology and Ph.D. from Aarhus University.